Investigators assessed sex differences in the risk for major cardiovascular events (MACE+) among patients with anemia of non-dialysis chronic kidney disease (CKD).
The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...
The division of myelodysplastic syndromes (MDS) into low-risk and high-risk categories guides prognosis and treatment, with patients who have lower-risk disease typically receivin ...
Using a deep learning AI model, researchers identified the first-of-its-kind biomarker of chronic stress detectable through routine imaging, according to research being presented next week at the ...
Can you benefit from light therapy? It depends. Treatments range from nonsensical to possibly useful to those proven to be effective.
Recent polling shows oncologists changing inclination in treatment for mHSPC based on tolerability profiles.
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback